| Net Cash Provided by (Used in) Operating Activities |
$19,913 |
USD |
43% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$19,513 |
USD |
-51% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
750,000,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
38,962,050 |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$184 |
USD |
-96% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$1,183,679 |
USD |
3.7% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,183,679 |
USD |
3.7% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
130,000,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$5,195,456 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
$10,672 |
USD |
133% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q1 2026 |